These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22544322)

  • 21. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells.
    Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H
    Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An important role for RUNX3 in human L1 transcription and retrotransposition.
    Yang N; Zhang L; Zhang Y; Kazazian HH
    Nucleic Acids Res; 2003 Aug; 31(16):4929-40. PubMed ID: 12907736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RUNX3 is multifunctional in carcinogenesis of multiple solid tumors.
    Chuang LS; Ito Y
    Oncogene; 2010 May; 29(18):2605-15. PubMed ID: 20348954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway.
    Slattery ML; Lundgreen A; Herrick JS; Caan BJ; Potter JD; Wolff RK
    Carcinogenesis; 2011 Mar; 32(3):318-26. PubMed ID: 21088106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
    Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y
    Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
    Fowler M; Borazanci E; McGhee L; Pylant SW; Williams BJ; Glass J; Davis JN; Meyers S
    J Cell Biochem; 2006 Jan; 97(1):1-17. PubMed ID: 16237704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RUNX represses
    Hall A; Choi K; Liu W; Rose J; Zhao C; Yu Y; Na Y; Cai Y; Coover RA; Lin Y; Dombi E; Kim M; Levanon D; Groner Y; Boscolo E; Pan D; Liu PP; Lu QR; Ratner N; Huang G; Wu J
    Sci Adv; 2019 Apr; 5(4):eaau8389. PubMed ID: 31032403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upstream and downstream targets of RUNX proteins.
    Otto F; Lübbert M; Stock M
    J Cell Biochem; 2003 May; 89(1):9-18. PubMed ID: 12682904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay of transcription factors in T-cell differentiation and function: the role of Runx.
    Wong WF; Kohu K; Chiba T; Sato T; Satake M
    Immunology; 2011 Feb; 132(2):157-64. PubMed ID: 21091910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Runx3 and Cell Fate Decisions in Pancreas Cancer.
    Whittle MC; Hingorani SR
    Adv Exp Med Biol; 2017; 962():333-352. PubMed ID: 28299667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic RUNX3: A Link between p53 Deficiency and MYC Dysregulation.
    Date Y; Ito K
    Mol Cells; 2020 Feb; 43(2):176-181. PubMed ID: 31991537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GCP-WD is a gamma-tubulin targeting factor required for centrosomal and chromatin-mediated microtubule nucleation.
    Lüders J; Patel UK; Stearns T
    Nat Cell Biol; 2006 Feb; 8(2):137-47. PubMed ID: 16378099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-661 promotes non-small cell lung cancer progression by directly targeting RUNX3.
    Wang Y; Li Y; Wu B; Shi C; Li C
    Mol Med Rep; 2017 Aug; 16(2):2113-2120. PubMed ID: 28656235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcription Factors Runx1 and Runx3 Suppress Keratin Expression in Undifferentiated Keratinocytes.
    Ogawa E; Edamitsu T; Ohmori H; Kohu K; Kurokawa M; Kiyonari H; Satake M; Okuyama R
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077435
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Ito K; Otani S; Date Y
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RUNX3 in Stem Cell and Cancer Biology.
    Chuang LSH; Matsuo J; Douchi D; Bte Mawan NA; Ito Y
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of RUNX3 by histone methyltransferases.
    Lee YM
    J Cell Biochem; 2011 Feb; 112(2):394-400. PubMed ID: 21268059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RUNX3 regulates cell cycle-dependent chromatin dynamics by functioning as a pioneer factor of the restriction-point.
    Lee JW; Kim DM; Jang JW; Park TG; Song SH; Lee YS; Chi XZ; Park IY; Hyun JW; Ito Y; Bae SC
    Nat Commun; 2019 Apr; 10(1):1897. PubMed ID: 31015486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.